GlaxoSmithKline's total assets for Q1 2025 were £60.70B, an increase of 2.09% from the previous quarter. GB:GSK total liabilities were £47.05B for the fiscal quarter, a 1.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.